Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic J Kaye

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancerFrederic J Kaye
Molecular Cancer Therapeutics|June 11, 2009
Mutation-associated fusion cancer genes in solid tumorsFrederic J Kaye
Journal of the National Cancer Institute|May 5, 2005
A curious link between epidermal growth factor receptor amplification and survival: effect of "allele dilution" on gefitinib sensitivity?Frederic J Kaye
Oncogene|October 4, 2002
RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerFrederic J Kaye
Journal of the National Cancer Institute|November 13, 2008
Defining a candidate lung cancer geneFrederic J Kaye
Journal of the National Cancer Institute|March 14, 2015
Re: a cancer theory kerfuffle can lead to new lines of researchFrederic J Kaye
Journal of the National Cancer Institute|July 3, 2003
New leads suggest a clinically relevant genotype-phenotype relationship for the p53 geneFrederic J Kaye, Takefumi Komiya
Journal of the National Cancer Institute|March 5, 2004
For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivorsFrederic J Kaye, J William Harbour
The New England Journal of Medicine|June 17, 2011
Erlotinib or gefitinib for non-small-cell lung cancerFrederic J Kaye, Michael A Jantz, Jennifer Dallas
Head & Neck|May 17, 2013
The 3rd Salivary Gland Tumor Workshop meeting reportAdel K El-Naggar, Frederic J Kaye, Göran Stenman
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancerFrederic J Kaye
Molecular Cancer Therapeutics|June 11, 2009
Mutation-associated fusion cancer genes in solid tumorsFrederic J Kaye
Journal of the National Cancer Institute|May 5, 2005
A curious link between epidermal growth factor receptor amplification and survival: effect of "allele dilution" on gefitinib sensitivity?Frederic J Kaye
Oncogene|October 4, 2002
RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerFrederic J Kaye
Journal of the National Cancer Institute|November 13, 2008
Defining a candidate lung cancer geneFrederic J Kaye
Journal of the National Cancer Institute|March 14, 2015
Re: a cancer theory kerfuffle can lead to new lines of researchFrederic J Kaye
Journal of the National Cancer Institute|July 3, 2003
New leads suggest a clinically relevant genotype-phenotype relationship for the p53 geneFrederic J Kaye, Takefumi Komiya
Journal of the National Cancer Institute|March 5, 2004
For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivorsFrederic J Kaye, J William Harbour
The New England Journal of Medicine|June 17, 2011
Erlotinib or gefitinib for non-small-cell lung cancerFrederic J Kaye, Michael A Jantz, Jennifer Dallas
Head & Neck|May 17, 2013
The 3rd Salivary Gland Tumor Workshop meeting reportAdel K El-Naggar, Frederic J Kaye, Göran Stenman
Pageof 8